Temporal course of depressive symptoms during the development of Alzheimer disease
- PMID: 20603481
- PMCID: PMC2906401
- DOI: 10.1212/WNL.0b013e3181e620c5
Temporal course of depressive symptoms during the development of Alzheimer disease
Abstract
Objective: To characterize change in depressive symptoms before and after the onset of dementia in Alzheimer disease (AD).
Method: We used data from the Chicago Health and Aging Project, a longitudinal cohort study of risk factors for AD in a geographically defined population of old people. Two subsets were analyzed. In 357 individuals who developed incident AD during the study, self-report of depressive symptoms (Center for Epidemiologic Studies Depression Scale) was obtained at 3-year intervals for a mean of 8 to 9 years. In 340 individuals who agreed to annual data collection, informant report of depressive symptoms (Hamilton Depression Rating Scale) was obtained for a mean of 3 years after a diagnosis of AD (n = 107), mild cognitive impairment (n = 81), or no cognitive impairment (n = 152).
Results: The incident AD group reported a barely perceptible increase in depressive symptoms during 6 to 7 years of observation before the diagnosis (0.04 symptoms per year) and no change during 2 to 3 years of observation after the diagnosis except for a slight decrease in positive affect. In those with annual follow-up, neither AD nor its precursor, mild cognitive impairment, was associated with change in informant report of depressive symptoms during a mean of 3 years of observation.
Conclusion: Depressive symptoms show little change during the development and progression of AD to a moderate level of dementia severity.
Figures


Comment in
-
Blowing hot and cold over depression and cognitive impairment.Neurology. 2010 Jul 6;75(1):12-4. doi: 10.1212/WNL.0b013e3181e8cc2f. Neurology. 2010. PMID: 20603480 No abstract available.
-
Temporal course of depressive symptoms during the development of Alzheimer disease: blowing hot and cold over depression and cognitive impairment.Neurology. 2011 Apr 26;76(17):1531; author reply 1531, discussion 1531-2. doi: 10.1212/WNL.0b013e318210e7d5. Neurology. 2011. PMID: 21519007 No abstract available.
References
-
- Berger AK, Fratiglioni L, Forsell Y, Winbald B, Backman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998–2002. - PubMed
-
- Devanand DP, Sano M, Tang MX, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175–182. - PubMed
-
- Gatz JL, Tyas SL, St. John P, Montgomery P. Do depressive symptoms predict Alzheimer's disease and dementia? J Gerontol A Biol Sci Med Sci 2005;60:744–747. - PubMed
-
- Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004;61:1290–1293. - PubMed
-
- Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364–370. - PubMed
Publication types
MeSH terms
Grants and funding
- R01ES010902/ES/NIEHS NIH HHS/United States
- AG030146/AG/NIA NIH HHS/United States
- AG021972/AG/NIA NIH HHS/United States
- AG 022018/AG/NIA NIH HHS/United States
- U24 AG021886/AG/NIA NIH HHS/United States
- R01 HL084209/HL/NHLBI NIH HHS/United States
- K23AG030944-0251/AG/NIA NIH HHS/United States
- R01AG11101/AG/NIA NIH HHS/United States
- AG 033172/AG/NIA NIH HHS/United States
- P30AG10161/AG/NIA NIH HHS/United States
- AG036650/AG/NIA NIH HHS/United States
- R01AG009966/AG/NIA NIH HHS/United States
- AG09966/AG/NIA NIH HHS/United States
- AG11101/AG/NIA NIH HHS/United States
- ES10902/ES/NIEHS NIH HHS/United States
- U24 AG056270/AG/NIA NIH HHS/United States
- R01AG09966/AG/NIA NIH HHS/United States
- R01AG031553/AG/NIA NIH HHS/United States
- R01AG024871/AG/NIA NIH HHS/United States
- R01 AG032247/AG/NIA NIH HHS/United States
- AG12505/AG/NIA NIH HHS/United States
- HL084209/HL/NHLBI NIH HHS/United States
- R01 ES010902/ES/NIEHS NIH HHS/United States
- R01AG032247/AG/NIA NIH HHS/United States
- R01AG017917/AG/NIA NIH HHS/United States
- R01 AG011101/AG/NIA NIH HHS/United States
- R01AG15819/AG/NIA NIH HHS/United States
- R01 AG041797/AG/NIA NIH HHS/United States
- U01AG016979/AG/NIA NIH HHS/United States
- AG10161/AG/NIA NIH HHS/United States
- R01AG021972/AG/NIA NIH HHS/United States
- U24AG026395/AG/NIA NIH HHS/United States
- R01NR009543/NR/NINR NIH HHS/United States
- R01ES10902-01/ES/NIEHS NIH HHS/United States
- P30AG010161/AG/NIA NIH HHS/United States
- R01AG022018/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical